Showing results (371-380 of 480) with videos related to

Sort By:
Pageof 48
Nucleic Acids Research|November 29, 2014
Identification of SMG6 cleavage sites and a preferred RNA cleavage motif by global analysis of endogenous NMD targets in human cellsSkye A Schmidt, Patricia L Foley, Dong-Hoon Jeong, et al.
Journal of the American Heart Association|November 8, 2021
Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease RiskDeepak Palakshappa, Edward H Ip, Seth A Berkowitz, et al.
Frontiers in Cellular and Infection Microbiology|January 30, 2023
Investigation of microorganisms in cannabis after heating in a commercial vaporizerDanielle S Sopovski, Jing Han, Marla Stevens-Riley, et al.
Early Intervention in Psychiatry|November 19, 2016
Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?Lisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Journal of Long-Term Effects of Medical Implants|February 18, 2005
Vaccine information statements. Revolutionary but neglected educational advances in healthcare in the United StatesRichard F Edlich, Marcus L Martin, Marni L Foley, et al.
JAMIA Open|February 5, 2025
Using routinely available electronic health record data elements to develop and validate a digital divide risk scoreJamie M Faro, Emily Obermiller, Corey Obermiller, et al.
BMC Bioinformatics|November 26, 2013
Data mining tools for Salmonella characterization: application to gel-based fingerprinting analysisWen Zou, Hailin Tang, Weizhong Zhao, et al.
Scientific Reports|October 29, 2015
The commensal infant gut meta-mobilome as a potential reservoir for persistent multidrug resistance integronsAnuradha Ravi, Ekaterina Avershina, Steven L Foley, et al.
Schizophrenia Research|September 27, 2016
The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosisLisa Anne Hahn, Andrew Mackinnon, Debra L Foley, et al.
Blood|October 24, 2002
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximabAdam D Kennedy, Michael D Solga, Theodore A Schuman, et al.
Pageof 48